165 related articles for article (PubMed ID: 37849254)
1. [Risk factor analysis of lymph node metastasis in endometrial carcinoma combined with molecular types].
Li LL; Li H; Li J; Zhang XB; Wang ZQ; Shen DH; Wang JL
Zhonghua Fu Chan Ke Za Zhi; 2023 Oct; 58(10):733-741. PubMed ID: 37849254
[No Abstract] [Full Text] [Related]
2. [Application and clinical significance of TCGA molecular classification in endometrial cancer].
Zhao LY; Dai YB; Li LW; Wang ZQ; Wang JL
Zhonghua Fu Chan Ke Za Zhi; 2021 Oct; 56(10):697-704. PubMed ID: 34823319
[No Abstract] [Full Text] [Related]
3. Lymphovascular space invasion and positive pelvic lymph nodes are independent risk factors for para-aortic nodal metastasis in endometrioid endometrial cancer.
Solmaz U; Mat E; Dereli ML; Turan V; Tosun G; Dogan A; Sanci M; Ozdemir IA; Pala EE
Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():63-7. PubMed ID: 25638600
[TBL] [Abstract][Full Text] [Related]
4. Relationship between molecular markers and lymphadenectomy and lymphovascular space invasion in endometrial cancer.
Bilir F; Arıoz DT; Arıkan SE; Yalcın GS; Ozdemir C; Demir H; Chkhikvadze M; Ozdemir CY; Cicekli N; Vatansever N; Yılmaz S
Arch Gynecol Obstet; 2023 Sep; 308(3):941-946. PubMed ID: 36959366
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for paraaortic lymph node metastasis in endometrial cancer.
Sari ME; Yalcin İ; Sahin H; Meydanli MM; Gungor T
Int J Clin Oncol; 2017 Oct; 22(5):937-944. PubMed ID: 28523533
[TBL] [Abstract][Full Text] [Related]
6. Re-stratification of patients with copy-number low endometrial cancer by clinicopathological characteristics.
Liwei L; He L; Yibo D; Luyang Z; Zhihui S; Nan K; Danhua S; Junzhu W; Zhiqi W; Jianliu W
World J Surg Oncol; 2023 Oct; 21(1):332. PubMed ID: 37865800
[TBL] [Abstract][Full Text] [Related]
7. Lymphovascular space invasion and cervical stromal invasion are independent risk factors for nodal metastasis in endometrioid endometrial cancer.
Solmaz U; Mat E; Dereli M; Turan V; Gungorduk K; Hasdemir P; Tosun G; Dogan A; Ozdemir A; Adiyeke M; Sanci M
Aust N Z J Obstet Gynaecol; 2015 Feb; 55(1):81-6. PubMed ID: 25688821
[TBL] [Abstract][Full Text] [Related]
8. [Clinical analysis on the lymph nodes metastasis characters and their relation with the prognosis of the endometrial carcinoma patients].
Wang ZQ; Zhang Y; Wang JL; Shen DH; Zhao X; Yao YY; Bai Y; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2011 Jun; 46(6):435-40. PubMed ID: 21781585
[TBL] [Abstract][Full Text] [Related]
9. TCGA molecular subgroups and FIGO grade in endometrial endometrioid carcinoma.
Travaglino A; Raffone A; Mollo A; Borrelli G; Alfano P; Zannoni GF; Insabato L; Zullo F
Arch Gynecol Obstet; 2020 May; 301(5):1117-1125. PubMed ID: 32253551
[TBL] [Abstract][Full Text] [Related]
10. A novel multivariable prediction model for lymphatic dissemination in endometrioid endometrial cancer: The lymph node Metastasis Risk Index.
Meydanli MM; Aslan K; Oz M; Muftuoglu KH; Yalcin I; Engin-Ustun Y
Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():310-315. PubMed ID: 31377459
[TBL] [Abstract][Full Text] [Related]
11. Risk Factors for Lymph Node Metastasis among Lymphovascular Space Invasion-Positive Women with Endometrioid Endometrial Cancer Clinically Confined to the Uterus.
Sarı ME; Meydanlı MM; Yalçın I; Şahin H; Çoban G; Çelik H; Kuşçu E; Gungor T; Ayhan A
Oncol Res Treat; 2018; 41(12):750-754. PubMed ID: 30419557
[TBL] [Abstract][Full Text] [Related]
12. Lymph node metastasis in endometrioid adenocarcinomas of the uterine corpus with occult cervical involvement.
Boren T; Lea J; Kehoe S; Miller DS; Richardson D
Gynecol Oncol; 2012 Oct; 127(1):43-6. PubMed ID: 22713294
[TBL] [Abstract][Full Text] [Related]
13. The association of polypoid growth pattern with lymph node involvement in endometrioid type endometrial adenocarcinoma.
Bezircioglu I; Yetimalar MH; Kilic D; Yigit S
Indian J Cancer; 2023; 60(2):230-236. PubMed ID: 37530246
[TBL] [Abstract][Full Text] [Related]
14. [Correlation between the primary tumor size of endometrial carcinoma and lymph node metastasis and recurrence].
Guo CM; Dai YB; Geng J; Li H; Dong YY; Wang ZQ; Wang JL
Zhonghua Fu Chan Ke Za Zhi; 2021 Apr; 56(4):264-270. PubMed ID: 33902238
[No Abstract] [Full Text] [Related]
15. Lymphovascular space invasion in microcystic elongated and fragmented (MELF)-pattern well-differentiated endometrioid adenocarcinoma is associated with a higher rate of lymph node metastasis.
Hertel JD; Huettner PC; Pfeifer JD
Int J Gynecol Pathol; 2014 Mar; 33(2):127-34. PubMed ID: 24487466
[TBL] [Abstract][Full Text] [Related]
16. Lymph Node Metastasis in Patients With Endometrioid Endometrial Cancer: Overtreatment Is the Main Issue.
Karalok A; Turan T; Basaran D; Turkmen O; Comert Kimyon G; Tulunay G; Tasci T
Int J Gynecol Cancer; 2017 May; 27(4):748-753. PubMed ID: 28301338
[TBL] [Abstract][Full Text] [Related]
17. Ovarian metastasis risk factors in endometrial carcinoma: A systematic review and meta-analysis.
Liang X; Zeng H; Chen S; Jiang M; Liu S; Fan J
Eur J Obstet Gynecol Reprod Biol; 2021 Dec; 267():245-255. PubMed ID: 34837854
[TBL] [Abstract][Full Text] [Related]
18. Cervical invasion, lymphovascular space invasion, and ovarian metastasis as predictors of lymph node metastasis and poor outcome on stages I to III endometrial cancers: a single-center retrospective study.
Li M; Wu S; Xie Y; Zhang X; Wang Z; Zhu Y; Yan S
World J Surg Oncol; 2019 Nov; 17(1):193. PubMed ID: 31733657
[TBL] [Abstract][Full Text] [Related]
19. Predicting Factors for Pelvic Lymph Node Metastasis in Patients with Apparently Early-Stage Endometrial Cancer.
Gumtorntip P; Poomtavorn Y; Tanprasertkul C
Asian Pac J Cancer Prev; 2022 Feb; 23(2):617-622. PubMed ID: 35225474
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for pelvic lymph node metastasis in endometrial cancer.
Li Y; Cong P; Wang P; Peng C; Liu M; Sun G
Arch Gynecol Obstet; 2019 Oct; 300(4):1007-1013. PubMed ID: 31435773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
